EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and safety of 1064‐nm fractional picosecond laser for the treatment of postmastectomy scars in transgender men: A randomized controlled trial

Suthinee Rutnin iD, Tanat Yongpisarn, Nawara Sakpuwadol, Amornrut Namasondhi, Cherrin Pomsoong, Teerapong Rattananukrom, Kunlawat Thadanipon

Lasers in Surgery and Medicine · 2024

DOI: 10.1002/lsm.23775 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Suthinee Rutnin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Cicatrix, Hypertrophic, Lasers, Gas, Transgender Persons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Subcutaneous mastectomy is a crucial component of gender affirmation therapy for transgender men (TM), but the scars that result from this procedure can frequently impair their quality of life. This study aimed to assess the efficacy and safety of 1064‐nm fractional picosecond laser (FxPico) treatment for hypertrophic and atrophic postmastectomy scars in TM.

Methods

Twenty‐two patients with a total of 35 pairs of bilateral symmetric mastectomy scars were enrolled. One of each pair of symmetric scars was randomly assigned to receive four FxPico treatments at 4‐week intervals. All scars were evaluated using the modified Vancouver Scar Scale (mVSS) and three‐dimensional imaging for scar roughness, melanin index, and hemoglobin index before each treatment session and at 1, 3, and 6 months following the last treatment. Additionally, participant‐rated scar satisfaction (PSS) and scar improvement (Global Assessment Score, GAS), as well as adverse events were recorded.

Results

During the 6‐month follow‐up period after the end of laser treatment sessions, the treated scars showed significant reductions in the mVSS compared to the untreated controls ( p < 0.001), whereas the melanin index and hemoglobin index were not significantly different. Subgroup analysis of hypertrophic scars demonstrated statistically significant reductions in mVSS at 1 ( p = 0.003) and 3 months ( p = 0.041) after the end of laser treatments. PSS was significantly higher on the laser‐treated scars than the controls ( p = 0.008), and a participant‐rated GAS of 2.95 ± 0.65 was found. There were no serious adverse events reported.

Conclusions

1064‐nm FxPico could be utilized to treat mastectomy scars among TM, particularly the hypertrophic type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCicatrix, HypertrophicLasers, GasTransgender PersonsHumansMaleCicatrixHemoglobinsHypertrophyLasersMastectomyMelaninsQuality of LifeTreatment OutcomeFemale

Stichwörter der Autor:innen

atrophic scarhypertrophic scarpicosecond laserpostmastectomy scartransgender mentransmasculine individualstransmen

Substanzen

HemoglobinsMelanins

Autor:innen und Institutionen

  • Division of Dermatology, Mahidol University, Bangkok, Thailand.
  • Department of Clinical Epidemiology and Biostatistics, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Suthinee Rutnin

Zitieren

APA

Rutnin, S., Yongpisarn, T., Sakpuwadol, N., Namasondhi, A., Pomsoong, C., Rattananukrom, T., & Thadanipon, K. (2024). Efficacy and safety of 1064‐nm fractional picosecond laser for the treatment of postmastectomy scars in transgender men: A randomized controlled trial. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23775

Vancouver

Rutnin S, Yongpisarn T, Sakpuwadol N, Namasondhi A, Pomsoong C, Rattananukrom T, et al. Efficacy and safety of 1064‐nm fractional picosecond laser for the treatment of postmastectomy scars in transgender men: A randomized controlled trial. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23775

BibTeX
@article{Rutnin2024,
  author = {Rutnin, Suthinee and Yongpisarn, Tanat and Sakpuwadol, Nawara and Namasondhi, Amornrut and Pomsoong, Cherrin and Rattananukrom, Teerapong and Thadanipon, Kunlawat},
  title = {Efficacy and safety of 1064‐nm fractional picosecond laser for the treatment of postmastectomy scars in transgender men: A randomized controlled trial},
  journal = {Lasers in Surgery and Medicine},
  year = {2024},
  doi = {10.1002/lsm.23775}
}
Kostenlos starten →